Oscar Health, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oscar Health, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q2 2024.
  • Oscar Health, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was $67.8M.
  • Oscar Health, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $49.6M.
  • Oscar Health, Inc. annual Operating Income (Loss) for 2023 was -$236M, a 60.1% increase from 2022.
  • Oscar Health, Inc. annual Operating Income (Loss) for 2022 was -$590M, a 8.34% decline from 2021.
  • Oscar Health, Inc. annual Operating Income (Loss) for 2021 was -$544M, a 35.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $49.6M $67.8M +$74.3M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$24.7M $186M +$211M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$236M -$145M +$77M +34.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 -$313M -$58.2M +$134M +69.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$447M -$6.53M +$100M +93.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$547M -$25.4M +$43.2M +63% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$590M -$222M -$26.2M -13.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 -$564M -$192M +$19.3M +9.12% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$583M -$106M -$34M -46.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$549M -$68.5M -$4.49M -7.01% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$544M -$196M -$9.42M -5.04% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 -$535M -$212M -$132M -164% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$404M -$72.5M -$33.2M -84.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$370M -$64M +$31.9M +33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$402M -$187M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$80.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$39.4M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$95.9M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.